Prenatal screening for infectious diseases: An analysis of disparities and adherence to policy in California

Maternal and Child Health Journal

Volumn 13, Issue 2, 2009, Pages 260-267

  Sheikh, Lamiya A ^a   Sarnquist, Clea ^a   Grieb, Erin Moix ^a   Sullivan, Barbara ^a   Maldonado, Yvonne A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

California; Infectious diseases; Prenatal; Screening

Indexed keywords

CALIFORNIA; COMMUNICABLE DISEASES; FEMALE; GUIDELINE ADHERENCE; HEALTHCARE DISPARITIES; HUMANS; MASS SCREENING; MEDICAL AUDIT; PRENATAL CARE;

EID: 59849122174     PISSN: 10927875     EISSN: 15736628     Source Type: Journal    
DOI: 10.1007/s10995-008-0341-5     Document Type: Article

References (39)

1. Centers for Disease Control, Prevention. (2001). Control and prevention of rubella: Evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR. Morbidity and Mortality Weekly Report, 50 (RR-12), 1-29.
2. Recommendations of the Advisory Committee on Immunization Practices. (1988). Prevention of perinatal transmission of hepatitis B virus: Prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR. Morbidity and Mortality Weekly Report, 37 (22), 341-351.
3. Epidemiologic Notes and Reports Maternal Hepatitis B Screening Practices--California, Connecticut, Kansas, and United States, 1992-1993. (1994). MMWR. Morbidity and Mortality Weekly Report, 43 (17), 311,317-320.
4. Centers for Disease Control, Prevention. (1988). Guidelines for the prevention and control of congenital syphilis. MMWR. Morbidity and Mortality Weekly Report, 37 (S-1), 1-13.
5. California Codes. Health and Safety Code Section 120675-120715.
6. American Academy of Pediatrics, Committee on Infectious Diseases, Committee on Fetus and Newborn. (1992). Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics, 90, 775-778.
7. Centers for Disease Control, Prevention. (1995). U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR. Morbidity and Mortality Weekly Report, 44 (RR-7), 1-14.
8. Centers for Disease Control, Prevention. (1996). Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR. Morbidity and Mortality Weekly Report, 45 (RR-7), 1-24.
9. American College of Obstetricians, Gynecologists, Committee on Obstetric Practice. (1996). Prevention of early-onset group B streptococcal disease in newborns [Opinion 173]. Washington, D.C.: ACOG.
10. American Academy of Pediatrics, Committee on Infectious Diseases/ Committee on Fetus, Newborn. (1997). Revised guidelines for prevention of early-onset group B streptococcal (GBS) disease. Pediatrics, 99, 489-496.
11. Centers for Disease Control, Prevention. (2002). Prevention of perinatal group B streptococcal disease: Revised guidelines from CDC. MMWR. Morbidity and Mortality Weekly Report, 51 (RR-11), 1-22.
12. Centers for Disease Control, Prevention. (2007). Perinatal group B Streptococcal disease after universal screening recommendations--United States, 2003-2005. MMWR. Morbidity and Mortality Weekly Report, 56 (28), 701-705.
13. Centers for Disease Control, Prevention. (2001). Revised recommendations for HIV screening of pregnant women. MMWR. Morbidity and Mortality Weekly Report, 50 (No. RR-19), 63-85.
14. Centers for Disease Control, Prevention. (2003). Advancing HIV prevention: New strategies for a changing epidemic - United States, 2003. MMWR. Morbidity and Mortality Weekly Report, 52, 329-332.
15. Centers for Disease Control, Prevention. (2000). Entry into prenatal care: United States 1989-1997. MMWR. Morbidity and Mortality Weekly Report, 49, 393-398.
16. Ingram, D. D. (1986). National and state trends in use of prenatal care, 1970-83. American Journal of Public Health, 76 (4), 415-423.
17. Kalmuss, D. (1990). Barriers to prenatal care among low-income women in New York City. Family Planning Perspectives, 22 (5), 215-218, 231.
18. Jessop, A. (1995). Assessment of screening, treatment, and prevention of perinatal infections in the Philadelphia Birth cohort. American Journal of Medical Quality, 20 (5), 253-261.
19. Centers for Disease Control, Prevention. (2002). HIV testing among pregnant women - United States and Canada, 1998-2001. MMWR. Morbidity and Mortality Weekly Report, 51 (45), 1013-1016.
20. California Codes. Health and Safety Code Section SB 889:125107.
21. Schrag, S. J., et al. (2003). Prenatal screening for infectious diseases and opportunities for prevention. Obstetrics and Gynecology, 102 (4), 753-760.
22. California Birth Cohort. (2000-2003). Department of Health Services, Office of Health Information and Research, California.
23. Cowgill, K. (2003). Report from the CDC. Awareness of perinatal group B streptococcal infection among women of childbearing age in the United States, 1999 and 2002. Womens Health (Larchmt), 12 (6), 527-532.
24. Sarnquist, C. (2007). Evaluation of the relationship between state and national policy and implementation of perinatal HIV prevention interventions. American Journal of Public Health, 97 (6), 1041-1046.
25. Lansky, A., et al. (1999). Adequacy of prenatal care and prescription of zidovudine to prevent perinatal HIV transmission. Journal of Acquired Immune Deficiency Syndromes, 21 (3), 223-227.
26. Wilson, T., et al. (2004). Prenatal care utilization and the implementation of prophylaxis to prevent perinatal HIV-1 transmission. Maternal and Child Health Journal, 8 (1), 13-18.
27. Hogben, M. (2002). Sexually transmitted disease screening by United States obstetricians and gynecologists. Obstetrics and Gynecology, 100 (4), 801-807.
28. Kropp, R. Y., et al. (2005). Unique challenges to preventing perinatal HIV transmission among Hispanic women in California: Results of a needs assessment. AIDS Education And Prevention, 17 (1), 22-40.
29. Roome, A., et al. (1999). Testing pregnant women for HIV: A survey of obstetricians and review of patient prenatal/obstetric medical records-Connecticut 1996-1997. Connecticut Medicine, 63, 541.
30. Braveman, P., et al. (1993). Access to prenatal care following major Medicaid eligibility expansions. JAMA, 269 (10), 1285-1289.
31. Schuman, P. (2004). Voluntary HIV counseling and testing of pregnant women-an assessment of compliance with Michigan public health statutes. Medscape General Medicine, 6 (2), 52.
32. Hessol, N. A., et al. (2004). Reduced risk of inadequate prenatal care in the era after Medicaid expansions in California. Medical Care, 42 (5), 416-422.
33. Meade, C., Sikkema, K. J. (2005). Voluntary HIV testing among adults with severe mental illness: Frequency and associated factors. AIDS Behaviour, 9 (4), 465-473.
34. Rosenberg S., et al. (2001). Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health, 91, 31-37.
35. Hammett, T. M., et al. (2002). The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. American Journal of Public Health, 92, 1789-1794.
36. Maruschak, L. (1999). HIV in prisons and jails. Washington, DC: Bureau of Justice Statistics, July 2001 (NCJ 187456).
37. Hammett, T. M. (2006). HIV/AIDS, sexually transmitted diseases, and incarceration among women: National and southern perspectives. Sexually Transmitted Diseases, 33 (7 Suppl), S17-S22.
38. Public Health Legislation. (2006). California legislative session. AB 2383 (Dymally). Inmate Medical Testing.
39. Schuchat, A., et al. (2002). Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections. Maternal and Child Health Journal, 6 (2), 107-114.